Potassium%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520chloride

# Potassium Chloride ## Overview Potassium chloride (KCl) is an electrolyte supplement used to treat or prevent hypokalemia. It is available in various formulations, including oral tablets, capsules, liquids, and intravenous (IV) solutions. ## Primary Indications * Treatment of hypokalemia. * Prevention of hypokalemia in patients at risk. ## Adult Dosing Dosing is highly individualized based on serum potassium levels, clinical condition, and acid-base status. * **Treatment of Hypokalemia:** * Oral: Typical doses range from 20-100 mEq per day, divided into 1-4 doses. Severe hypokalemia may require higher doses under close monitoring. * IV: Recommended doses for severe hypokalemia typically range from 10-40 mEq per hour, added to a compatible IV fluid. **Crucially, the maximum infusion rate should not exceed 20 mEq/hour and the maximum concentration should not exceed 40 mEq/L to minimize the risk of cardiac arrest.** Higher infusion rates (>20 mEq/hour) and concentrations (>40 mEq/L) should only be administered in critical care settings with continuous ECG monitoring. * **Prevention of Hypokalemia:** * Oral: 20-40 mEq per day. ## Pediatric Dosing Dosing is individualized based on weight and serum potassium levels. Local protocol should be consulted. * **Oral:** Typical maintenance doses range from 1-3 mEq/kg/day, not to exceed adult doses. * **IV:** Typically 0.5-1 mEq/kg per dose, infused at a rate not exceeding 0.3-0.5 mEq/kg/hour. **Maximum concentration for peripheral IV infusion is usually 40 mEq/L, and for central IV infusion is usually 100 mEq/L.** **Maximum infusion rate should not exceed 10-20 mEq/hour in most pediatric patients.** Continuous ECG monitoring is essential for IV potassium administration, especially at higher rates or concentrations. ## Dose Adjustments * **Renal Impairment:** Dose reduction is necessary. Monitor serum potassium closely. In severe renal impairment, potassium supplementation may be contraindicated. * **Acidosis:** May require higher doses of potassium due to intracellular shifts. * **Alkalosis:** May require lower doses of potassium due to intracellular shifts. ## Contraindications * Hyperkalemia. * Conditions causing the immediate risk of hyperkalemia (e.g., severe renal impairment, untreated Addison's disease, certain types of heart block). * Known hypersensitivity to potassium chloride. ## Adverse Effects * **Most Serious:** Cardiac arrhythmias (including cardiac arrest, especially with rapid IV infusion), hyperkalemia. * **Gastrointestinal:** Nausea, vomiting, diarrhea, abdominal pain, GI obstruction, ulceration, bleeding (especially with sustained-release oral formulations). * **Other:** Weakness, paresthesias, confusion. ## Key Drug Interactions * **Potassium-sparing diuretics (e.g., spironolactone, amiloride, triamterene), ACE inhibitors, ARBs, NSAIDs, certain immunosuppressants (e.g., tacrolimus, cyclosporine):** Increased risk of hyperkalemia. * **Aldosterone antagonists:** Increased risk of hyperkalemia. * **Anticholinergics:** May increase absorption of sustained-release oral potassium chloride. * **Urinary alkalinizers (e.g., sodium bicarbonate):** May increase the rate of potassium excretion. ## Monitoring * **Serum potassium levels:** Monitor frequently, especially during initiation of therapy, dose changes, and in patients with renal impairment or risk factors for hyperkalemia. * **Renal function (BUN, creatinine):** Essential, particularly in patients with pre-existing renal disease. * **ECG:** Especially for IV potassium administration and in patients with baseline cardiac abnormalities or suspected hyperkalemia. * **Signs and symptoms of hypokalemia and hyperkalemia.** ## Clinical Pearls * Always dilute IV potassium chloride before administration. **Never administer as an undiluted bolus.** * Oral sustained-release formulations can cause significant gastrointestinal irritation; advise patients to take with food or meals. * Consider the source of potassium loss when treating hypokalemia (e.g., diuretics, vomiting, diarrhea). * Intramuscular administration of potassium is not recommended due to pain and risk of tissue necrosis. *** *This information is intended for healthcare professionals and does not substitute for professional medical advice. Always consult the most current prescribing information and relevant clinical guidelines before making any treatment decisions. Dosing may vary based on individual patient factors and local protocols.*